Info Obat dan Regulator Obat Dunia

F
Patient Engagement Collaborative
Replies
0
Views
328
FDA
F
F
Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet
Replies
0
Views
300
FDA
F
F
Medication Health Fraud
Replies
0
Views
289
FDA
F
F
Chapter 6 - Veterinary Medicine
Replies
0
Views
236
FDA
F
F
Guidance Recap Podcast | Bioavailability Studies Submitted in NDAs or INDs – General Considerations
Replies
0
Views
438
FDA
F
F
Bioavailability Studies Submitted in NDAs or INDs – General Considerations
Replies
0
Views
405
FDA
F
F
FDA Workshop on the Role of Phytosterols in PNALD/IFALD - 05/06/2022
Replies
0
Views
272
FDA
F
F
Proposed Rule: National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers - 04/13/2022
Replies
0
Views
300
FDA
F
F
Guidance Documents and MAPPs (BsUFA)
Replies
0
Views
266
FDA
F
F
OPDP Regulatory Information
Replies
0
Views
360
FDA
F
F
Generitech Corporation - 618333 - 03/01/2022
Replies
0
Views
269
FDA
F
F
Yusef Manufacturing Laboratories, LLC - 621026 - 02/08/2022
Replies
0
Views
337
FDA
F
F
Med Shop Total Care, Inc. - 628182 - 03/18/2022
Replies
0
Views
322
FDA
F
F
Ultra Seal Corporation - 624650 - 03/14/2022
Replies
0
Views
348
FDA
F
F
kubapharm.com - 622051 - 03/30/2022
Replies
0
Views
254
FDA
F
F
premiumlightsupplier.com - 622056 - 03/30/2022
Replies
0
Views
320
FDA
F
F
www.wellerectile.com - 615690 - 04/06/2022
Replies
0
Views
339
FDA
F
F
Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers
Replies
0
Views
346
FDA
F
F
Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injecti
Replies
0
Views
261
FDA
F
F
Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use
Replies
0
Views
246
FDA
F
You must log in or register to post here.
Top